A tribute to John Fish.

We are very saddened to tell you that CareToLive member John Fish passed away from prostate cancer on Tuesday, December 18, 2007, without ever having the benefit of receiving provenge, the immunotherapy which he so desperately wanted. He was so hopeful that he would be able to get it 7 months ago, when it came before the FDA Advisory Committee of experts who voted it unanimously safe and 13 to 4 substantial evidence of efficacy (2 of the naysayers who “leaked” letters may be called before a Congressional Hearing – read on). Instead the FDA delayed approval, claiming they needed more data. Over 10 years of trials showing survival benefits, were not enough for them, despite the fact that 30,000 American men with PC are out of options, and the treatment has almost no side effects or safety issues. The chicanery going on at the FDA knows no bounds.

We can never thank John enough for all his efforts to right the wrongs in the FDA delay of Provenge. John was one of the lead Plaintiffs in our unprecedented, ongoing, CareToLive lawsuit filed by our attorney Kerry Donahue against the FDA, unfortunately under appeal, but not in time to help John. It was dismissed under a Catch 22, whereby the Court refused to hear the case concerning the delay of Provenge due to the fact that is was not denied, only delayed, so far for 7 months and what could be forever. Tell John that it is still pending. A lot of good that does him. For all intents and purposes Provenge is dead, until the FDA Commissioner Andrew Von Eschenbach decides whether to approve, delay or not approve, depending on whatever baloney is being dished out over at the FDA that day. Continue Reading One Fish, Two Fish, We are all Blue Fish — John Fish We Will Miss You »

Popularity: 11%